17β‐estradiol reduces SARS‐CoV‐2 infection in vitro

17β‐estradiol reduces SARS‐CoV‐2 infection in vitro

Abstract The COVID‐19 has originated from Wuhan, China, in December 2019 and has been affecting the public health system, society, and economy in an unheard‐of manner. There is no specific treatment or vaccine available for COVID‐19. Previous data showed that men are more affected than women by COVI...

Full description

Bibliographic Details
Main Authors: Robertha Mariana Rodrigues Lemes, Angelica Jardim Costa, Cynthia Silva Bartolomeo, Taysa Bervian Bassani, Michelle Sayuri Nishino, Gustavo Jose da Silva Pereira, Soraya Soubhi Smaili, Rui Monteiro de Barros Maciel, Carla Torres Braconi, Edgar Ferreira da Cruz, Ana Lopez Ramirez, Juliana Terzi Maricatto, Luiz Mario Ramos Janini, Carla Máximo Prado, Roberta Sessa Stilhano, Rodrigo Portes Ureshino
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Physiological Reports
Subjects:
17β‐estradiol
COVID‐19
estrogen receptors
gender
SARS‐CoV‐2
VERO E6 cells
Online Access:https://doi.org/10.14814/phy2.14707

Internet

https://doi.org/10.14814/phy2.14707

Similar Items